Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2-Reference-Cited by-同舟云学术

Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2

Published:2021-01-07 Issue:6 Volume:32 Page:744-752
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Damaskinaki Foteini-Nafsika¹²³,Moran Luis A.¹⁴^ORCID,Garcia Angel⁴,Kellam Barrie²³^ORCID,Watson Steve P.¹²

Affiliation:

1. Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

2. Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, UK

3. Biodiscovery Institute, University Park, University of Nottingham, Nottingham, UK

4. Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain

Funder

British Heart Foundation

European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2020.1863939

Reference86 articles.

1. Functional significance of the platelet immune receptors GPVI and CLEC-2

2. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke

3. Platelets and vascular integrity

4. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Sites of the C‐type Lectin‐Like Fold;Chemistry – A European Journal;2024-04-30

2. C-type lectin-like receptor 2: roles and drug target;Thrombosis Journal;2024-03-19

3. Inflammation-related prognostic markers in resected hepatocellular carcinoma;Frontiers in Oncology;2023-12-07

4. Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI;Thrombosis and Haemostasis;2023-11-15

5. Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis;Frontiers in Pharmacology;2023-10-31